Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Immunotherapy
|
July 20, 2010
Conference scene--active immunotherapeutics forum: meeting highlights
Julianna Lisziewicz
Current Opinion in HIV and AIDS
|
April 18, 2009
Combining antiretroviral drugs and immune therapies: an approach to achieve clinical benefit after treatment interruption
Julianna Lisziewicz
Microbes and Infection
|
March 7, 2002
Structured treatment interruptions in HIV/AIDS therapy
Julianna Lisziewicz, Franco Lori
Immunotherapy
|
August 2, 2013
HIV vaccine to induce cytotoxic T cells recognizing conserved HIV-1/2-epitopes derived from the most frequent HLA types of the human population
Eszter Somogyi, Julianna Lisziewicz
Expert Opinion on Biological Therapy
|
July 2, 2003
2nd International Symposium on Molecular Diagnostics and Skin Gene Therapy
Julianna Lisziewicz, Franco Lori
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 5, 2012
Nanomedicine applications towards the cure of HIV
Julianna Lisziewicz, Enikő R Tőke
Journal of Immunological Methods
|
May 10, 2003
Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytes
Jianqing Xu, Franco Lori, Julianna Lisziewicz
Current Opinion in HIV and AIDS
|
April 18, 2009
Stopping HAART temporarily in the absence of virus rebound: exploring new HIV treatment options
Franco Lori, Andrea Foli, Julianna Lisziewicz
The Journal of Antimicrobial Chemotherapy
|
August 6, 2002
Structured treatment interruptions as a potential alternative therapeutic regimen for HIV-infected patients: a review of recent clinical data and future prospects
Franco Lori, Andrea Foli, Julianna Lisziewicz
Vaccine
|
January 18, 2003
Therapeutic vaccination for future management of HIV/AIDS
Julianna Lisziewicz, Nyasha Bakare, Franco Lori
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Immunotherapy
|
July 20, 2010
Conference scene--active immunotherapeutics forum: meeting highlights
Julianna Lisziewicz
Current Opinion in HIV and AIDS
|
April 18, 2009
Combining antiretroviral drugs and immune therapies: an approach to achieve clinical benefit after treatment interruption
Julianna Lisziewicz
Microbes and Infection
|
March 7, 2002
Structured treatment interruptions in HIV/AIDS therapy
Julianna Lisziewicz, Franco Lori
Immunotherapy
|
August 2, 2013
HIV vaccine to induce cytotoxic T cells recognizing conserved HIV-1/2-epitopes derived from the most frequent HLA types of the human population
Eszter Somogyi, Julianna Lisziewicz
Expert Opinion on Biological Therapy
|
July 2, 2003
2nd International Symposium on Molecular Diagnostics and Skin Gene Therapy
Julianna Lisziewicz, Franco Lori
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 5, 2012
Nanomedicine applications towards the cure of HIV
Julianna Lisziewicz, Enikő R Tőke
Journal of Immunological Methods
|
May 10, 2003
Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytes
Jianqing Xu, Franco Lori, Julianna Lisziewicz
Current Opinion in HIV and AIDS
|
April 18, 2009
Stopping HAART temporarily in the absence of virus rebound: exploring new HIV treatment options
Franco Lori, Andrea Foli, Julianna Lisziewicz
The Journal of Antimicrobial Chemotherapy
|
August 6, 2002
Structured treatment interruptions as a potential alternative therapeutic regimen for HIV-infected patients: a review of recent clinical data and future prospects
Franco Lori, Andrea Foli, Julianna Lisziewicz
Vaccine
|
January 18, 2003
Therapeutic vaccination for future management of HIV/AIDS
Julianna Lisziewicz, Nyasha Bakare, Franco Lori
Page
of 5